Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC | News
Search Refinements

OTC News

View news from other Pharmaceutical sectors:
61-75 of 1692 results
CVS/pharmacy commits to create safer communities via drug abuse prevention efforts
CVS/pharmacy, the retail division of CVS Health, is reinforcing its longstanding commitment in the fight against the nationwide epidemic of prescription drug abuse with a number of efforts launching this month.
Production & Manufacturing > OTC > News
US FDA approves Perrigo's generic version of Valeant's BenzaClin Gel
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved Perrigo's generic version of Valeant Pharmaceuticals' BenzaClin Topical Gel.
Production & Manufacturing > OTC > News
Study finds initial prescription fills can accurately predict long-term medication adherence
A new study by researchers at the CVS Health Research Institute and Brigham and Women’s Hospital provides evidence that patients’ patterns of medication fills in the first few months after starting on a chronic therapy accurately predict future medication adherence behavior.
Production & Manufacturing > OTC > News
Perrigo rejects Mylan's unsolicited exchange offer as inadequate
Perrigo board has rejected Mylan's unsolicited exchange offer as inadequate.
Production & Manufacturing > OTC > News
US House Committee OK’s reversal of ban on OTCs in health savings accounts
The US House of Representatives Ways and Means Committee has approved the reversal of ban on over-the-counter (OTCs) in health savings accounts.
Production & Manufacturing > OTC > News
Cardinal Health launches Hospital Quality at Home products
Cardinal Health has launched the Hospital Quality at Home brand, a new line of hospital-quality products available over the counter to help loved ones and caregivers transition care from the hospital to home.
Production & Manufacturing > OTC > News
Mylan offers to buy Perrigo
By PBA editorial
Mylan has started its formal offer to acquire all outstanding ordinary shares of Perrigo Company, which manufactures private label over-the-counter (OTC) pharmaceuticals.
Production & Manufacturing > OTC > News
Omega Pharma seeks CE Mark designation for BL-5010
BioLineRx's partner, Omega Pharma, now part of Perrigo, has submitted an application for CE Mark designation for BL-5010, a novel treatment for the non-surgical removal of skin lesions.
Production & Manufacturing > OTC > News
Absorb Health adds new supplements to inventory
By PBR Staff Writer
Dietary supplement and natural skin care firm Absorb Health has added various new supplements to its inventory.
Production & Manufacturing > OTC > News
Alvogen launches first generic Exelon patch in US
Alvogen has launched the first generic equivalent of Exelon patch (rivastigmine transdermal system) in the US.
Production & Manufacturing > OTC > News
Laccure develops new product for bacterial vaginosis treatment
By PBR Staff Writer
Swedish company Laccure has developed a new health product for the treatment and prevention of bacterial vaginosis in women.
Production & Manufacturing > OTC > News
Perrigo acquires GlaxoSmithKline's OTC drugs portfolio for €200m
By PBR Staff Writer
Irish pharmaceutical company Perrigo has completed the acquisition of a portfolio of OTC brands in the European Economic Area (EEA), Brazil and Australia, from GlaxoSmithKline (GSK) for €200m.
Production & Manufacturing > OTC > News
Culturelle debuts only triple-action immune boosting supplement to include probiotics
A leading immune health probiotic brand is bringing new innovation to the cough/cold aisle this month. Culturelle Advanced Immune Defense is the first supplement with a triple action immune boosting formula strengthened by probiotics. The product is now available on shelves at drug, grocery and mass retailers nationwide.
Production & Manufacturing > OTC > News
Allergan recalls specific lots of REFRESH Lacri-Lube, REFRESH P.M. 3.5g, FML 0.1%, and Blephamide in US
Allergan announced that it is conducting a voluntary recall down to consumer level of specific lots of its REFRESH Lacri-Lube 3.5g and 7g for dry eye, REFRESH P.M. 3.5g for dry eye, FML (fluorometholone ophthalmic ointment) 0.1% (sterile ophthalmic ointment topical anti-inflammatory agent for ophthalmic use, 3.5g), and Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile topical ophthalmic ointment combining an antibacterial and a corticosteroid, 3.5g.
Production & Manufacturing > OTC > News
HSRx nears completion of OTC acne treatment trial of HSRx 2121
By PBR Staff Writer
US-based biopharmaceutical firm HSRx Group is nearing completion of a clinical trial for its over-the-counter (OTC) acne treatment product, HSRx 2121.
Production & Manufacturing > OTC > News
61-75 of 1692 results